Defense Advanced Research Projects AgencyTagged Content List

Infectious Disease

Relating to ailments caused by pathogens

Showing 28 results for Disease + Countermeasures RSS
The Rapid Threat Assessment (RTA) program aims to provide critical information to speed production of medical countermeasures to protect U.S. forces against novel chemical and biological weapons. Such weapons have historically been mass-produced within a year of discovery. Development of countermeasures, however, currently takes far longer. Using current methods and technologies, researchers require decades of study to gain a cellular-level understanding of how new threat agents exert their effects.
Program Manager
CDR Jean-Paul Chretien joined DARPA as a program manager in 2020. His interests include disease and injury prevention, operational medicine, and biothreat countermeasures.
Program Manager
Dr. Rohit Chitale joined DARPA as a program manager in 2019. He is an infectious disease epidemiologist with more than 20 years of experience helping national and international organizations establish and lead programs related to infectious disease prevention and eradication, with specific expertise in the design and implementation of disease surveillance systems and the development of new disease control tools.
Program Manager
Dr. Seth Cohen joined DARPA as a Program Manager in August 2019. He is interested in novel materials, new approaches to therapeutics/countermeasures, and biological and chemical technologies for stabilization/acquisition of scarce resources.
09/03/2018
Our deployed service members are exposed to adversary activity and numerous naturally occurring or engineered threats including chemicals, viruses, and bacteria. To protect them, BTO is developing technologies that can rapidly detect and characterize these threats. In addition, BTO is developing novel biological approaches to sense and report adversary activities on land and at sea.